期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

ⅠB和ⅡA期宫颈癌患者术后生存评估体系建立与分析 被引量：3

下载PDF
导出
摘要 目的探讨宫颈癌术后预后相关因素，并建立评估体系方法对2003@1月至2012年12月170例ⅠB和ⅡA期宫颈癌患者的临床资料进行回顾性分析，明确影响预后的独立危险因素，构建Cox比例风险模型，并进行预测分析和验证结果血清CA125水平、盆腔淋巴结转移和淋巴血管间隙浸润是影响早期宫颈癌患者术后生存的负性独立危险因素，其中盆腔淋巴结转移是最重要的因素；受试者操作特征曲线和时间依赖受试者操作特征曲线分析均显示Cox模型的曲线下面积明显大于FIGO分期，结论结合独立危险因素及其回归系数建立的Cox模型能较好的预测早期宫颈癌患者术后临床结局该模型稳定可靠，且预测能力不随时间的延长而减弱，
作者 喻晴 楼向明
机构地区 杭州市第一人民医院
出处 《浙江临床医学》 2015年第3期401-402,共2页 Zhejiang Clinical Medical Journal
关键词 宫颈癌 预后 COX模型 危险因素
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献28

  • 1章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量：41
  • 2陈鲁,吕卫国,谢幸,陈怀增,俞华,倪型灏.子宫颈鳞癌Ⅰb～Ⅱa期患者预后预测系统的建立及其临床意义[J].中华妇产科杂志,2005,40(4):239-242. 被引量：25
  • 3陈雅卿,郑爱文,楼洪坤.ⅠB～ⅡB期前宫颈癌髂总淋巴结转移的临床分析[J].中华肿瘤防治杂志,2007,14(14):1097-1099. 被引量：8
  • 4Landoni F,Maneo A,Colombo A,et al.Randomised study of radical surgery versus radiotherapy for stage Ⅰ b-Ⅱ a cervical cancer.Lancet,1997,350:535-540.
  • 5Biewenga P,van der Velden J,Mol BW,et al.Validation of existing prognostic models in patients with early-stage cervical cancer.Gynecol Oncol,2009,115:277-284.
  • 6Aoki Y,Sasaki M,Watanabe M,et al.High-risk group in node-positive patients with stage ⅠB,ⅡA,and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.Gynecol Oncol,2000,77:305-309.
  • 7Pras E,Willemse PH,Canrinus AA,et al.Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment Int J Radiat Oncol Biol Phys,2002,52:23-32.
  • 8Esajas MD,Duk JM,de Bruijn HW,et al.Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.J Clin Oncol,2001,19:3960-3966.
  • 9Shimada M,Kigawa J,Nishimura R,et al.Ovarian metastasis in carcinoma of the uterine cervix.Gynecol Oncol,2006,101:234-237.
  • 10Landoni F,Zanagnolo V,Lovato-Diaz L,et al.Ovarian metastases in early-stage cervical cancer (I A2-J A):a multicenter retrospective study of 1965 patients.Int J Gynecol Cancer,2007,17:623-628.

共引文献120

同被引文献24

  • 1LEE J Y, LEE C, HAHN S K, et al. Prognosis of adenosquamous carcinoma compared with adenocarcinoma in uterine cervical can- cer: a systematic review and meta-analysis of observational stud- ies[J]. International Journal of Gynecological Cancer, 2014, 24(2): 289-294.
  • 2HALTIA U M, Bt2TZOW R, LEMINEN A, et al. FIGO 1988 versus 2009 staging for endometriai carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype[J]. Journal of Gynecologic Oncology, 2014, 25(1): 30-35.
  • 3THAKER N G, KLOPP A H, JHINGRAN A, et al. Survival out- comes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system[J]. Gynecologic Ontology, 2015, 136(2): 269-273.
  • 4GARCES A H I, DIAS M S F, NOGUEIRA-RODRIGUES A, etal. Staging cervical cancer-current and future perspectives[J]. Austin J Obstet Gynecol, 2014, 1(4): 4-7.
  • 5VIZZA E, CORRADO G, ZANAGNOLO V, et al. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: A muhi-institution study[J]. Gynecologic Oncology, 2014, 133(2): 180-185.
  • 6GILLISON M L, CASTELLSAGUI X, CHATURVEDI A, et al. Eurogin roadmap: eomparative epidemiology of HPV infection and associated cancers of the head and neck and cervix[J]. Intenaa- tional Journal of Cancer, 2014, 134(3)i 497-507.
  • 7CUSCHIERI K, BREWSTER D H, GRAHAM C, et al. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer[J]. International Journal of Cancer, 2014, 135(11): 2721-2726.
  • 8RAUCH G M, KAUR H, CHOI H, et al. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer[J]. Radiographics, 2014, 34(4): 1082-1098.
  • 9DYK P, JIANG N, SUN B, et al. Cervical gross tumor volume dose predicts local control using magnetic resonance imag- ing/diffusion-weighted imaging-guided high-dose-rate and positron emission tomegraphy/computed tomography-guided in- tensity modulated radiation therapy[J]. International Journal of Radiation Oncology Biology Physics, 2014, 90(4): 794-801.
  • 10GADDUCCI A, TANA R, COSIO S, et al. The serum assay of tumour markers in the prognostic evaluation, treatment monitor- ing and follow-up of patients with cervical cancer: a review of the literature[J]. Critical reviews in oncology/hematology, 2008, 66(1): 10-20.

引证文献3

二级引证文献54

浙江临床医学
2015年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部